Rapid identification of the predominant azole-resistant genotype in Candida tropicalis.

Candida tropicalis SNQ2 XYR1 MLST xylose reductase

Journal

FEMS yeast research
ISSN: 1567-1364
Titre abrégé: FEMS Yeast Res
Pays: England
ID NLM: 101085384

Informations de publication

Date de publication:
21 Oct 2024
Historique:
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

Candida tropicalis is a leading cause of non-albicans candidemia in tropical/sub-tropical areas and a predominant genotype of azole-resistant C. tropicalis clinical isolates belongs to clade 4. The aim of this study was to reveal markers for rapidly identifying the predominant azole-resistant Candida tropicalis genotype. We analysed XYR1, one of the six genes used in the multilocus sequence typing analysis, and SNQ2, an ATP-binding cassette (ABC) transporter in 281 C. tropicalis, including 120 and 161 from Taiwan and global areas, respectively. Intriguingly, the first 4-mer of codon sequences ATRA of CTRG_05 978 (96/119 vs. 21/162, p < 0.001, at phi = 0. 679) and the SNQ2 A2977G resulting in amino acid I993V alternation (105/118 vs.12/163, p < 0.001, at phi = 0.81) was significantly associated with the clade 4 genotype. The sensitivity and specificity of the clade 4 genotype detection with a combination of SNPs of CTRG_05 978 and SNQ2 were 0.812 and 0.994, respectively, at phi = 0.838. Furthermore, we successfully established a TaqMan SNP genotyping assay to identify the clade 4 genotype. Our findings suggest that to improve the management of C. tropicalis infections, rapidly identifying azole-resistant C. tropicalis by detecting SNPs of CTRG_05 978 and SNQ2 is promising.

Identifiants

pubmed: 39435647
pii: 7829348
doi: 10.1093/femsyr/foae025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of FEMS.

Auteurs

Kuo-Yun Tseng (KY)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.
Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan, ROC.

Yu-Chieh Liao (YC)

Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan, ROC.

Yin-Zhi Chen (YZ)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.

Feng-Chi Chen (FC)

Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan, ROC.

Feng-Jui Chen (FJ)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.

Huey-Kang Sytwu (HK)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.

Li-Yun Hsieh (LY)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.

Chung-Yu Lan (CY)

Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan, ROC.
Department of Life Science, National Tsing Hua University, Hsinchu, Taiwan, ROC.
School of Medicine, National Tsing Hua University, Hsinchu, Taiwan, ROC.

Hsiu-Jung Lo (HJ)

Taiwan Mycology Reference Center, Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, ROC.
School of Dentistry, China Medical University, Taichung, Taiwan, ROC.
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan, ROC.

Classifications MeSH